Member Info for ProcessGuy

JHFH (17:31 5th May)

If Singer held upwards of 200k shares wouldn't they have needed to issue a TR1 ? Doesn't matter really but just curious.

Is +10% enough to get a seat on the board? I think it is.

Oh dear, perhaps look at Dazpinks post at 12:49pm!

That's a a pretty chunky trade just been reported after hours.

Yes, its working now.

Toffers:

shorts listed on here (LSE) and Shorttracker are for those above the 0.5% declaration threshold only. The threshold is set by the FCA.

Jm1973: "Inthallo is Sneller, is it not?"

He's the founder of Inthallo.

10.4 million in late trades from yesterday just appeared.

Yep, 15.1% to nothing so may still have just below the 3% reporting threshold. Personally, I think he's sold the lot, why take a massive hit on 12% but keep 2.9%?

According to Google AI:

"An exact yearly figure for relapsed, refractory (rr) AML cases in the EU isn't available in the provided search results, but the incidence of AML in the EU was 23,705 in 2021, and between 45.5% and 80% of patients experience a first complete remission and subsequent relapse, depending on age and risk category, with a high proportion of those relapses falling into the refractory category. The percentage of AML patients who experience relapse ranges from 35% to over 85%, suggesting a significant number of relapsed/refractory cases. "

MrC (11:43)

Do you have source for the rough diamonds value per carat used in your calculation?

Mattrs27 (09:49)

There are only 5,361,267 issued shares in total.

I understand that if shares are held in an ISA then they cant be lent to third parties due to the tax wrapper status.

Well that's a surprise !"

Calibre of numpty is getting lower!

Ancient history known to all LTH's, and thankfully of no relevance today.

Wonderful RNS this morning, so pleased for the patients and their family's and friends.

Haywain, thank you for the reply. Additional thanks to all those who have contributed to this discussion today.

Going to be an exciting few weeks then!

If the HG-CT-1 is as successful as it appears to be does this also validate CDX as they both target the FLT-3 receptor?

I seem to remember there was a post/discussion on this a while ago but cant remember by whom and what the conclusion was.

The fourth horsemen of the apocalypse now appears to complete the set - Boom, Stu, Tuan and Aldebaran.